MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia
D. Schotte, R.X. De Menezes, F. Akbari Moqadam, L.M. Khankahdani, E. Lange-Turenhout, and C. Chen MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia Haematologica 96 5 2011 703 711
MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia
F. Akbari Moqadam, E.A. Lange-Turenhout, I.M. Ariës, R. Pieters, and M.L. den Boer MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia Leuk Res 37 10 2013 1315 1321
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis
A. Roy, I. Roberts, A. Norton, and P. Vyas Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis Br J Haematol 147 1 2009 3 12
MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
X.J. Li, X.Q. Luo, B.W. Han, F.T. Duan, P.P. Wei, and Y.Q. Chen MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways Br J Cancer 109 8 2013 2189 2198
(2013)Br J Cancer, vol.109, Issue.8, pp. 2189-2198
MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia
H. Zhang, X.Q. Luo, P. Zhang, L.B. Huang, Y.S. Zheng, and J. Wu MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia PLoS One 4 11 2009 e7826
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt
H. Pei, L. Li, B.L. Fridley, G.D. Jenkins, K.R. Kalari, and W. Lingle FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt Cancer Cell 16 3 2009 259 266